Drug Screening Using Novel IMD in Renal Cell Carcinoma
Condition(s):Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Kidney CancerLast Updated:June 22, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Kidney CancerLast Updated:June 22, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:November 18, 2021Not yet recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Kidney Cancer; Advanced Renal Cell CarcinomaLast Updated:December 5, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:April 4, 2023Not yet recruiting
Condition(s):Renal Cell CarcinomaLast Updated:August 4, 2022Not yet recruiting
Condition(s):Renal Cell CarcinomaLast Updated:June 5, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 24, 2021Not yet recruiting
Condition(s):Renal CancerLast Updated:July 7, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:March 7, 2024Recruiting
Condition(s):Kidney CancerLast Updated:January 30, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.